Supplementary Materials

Supplementary Material for:

Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy

Matthias Pinter and Rakesh K. Jain*

*Corresponding author. Email: jain{at}steele.mgh.harvard.edu

Published 4 October 2017, Sci. Transl. Med. 9, eaan5616 (2017)
DOI: 10.1126/scitranslmed.aan5616

This PDF file includes:

  • Table S1. RASi approved by the FDA.
  • Table S2. Published prospective studies using RASi in different types of cancer.
  • Table S3. Published retrospective studies using RASi in different types of cancer.
  • Table S4. Ongoing prospective studies investigating the effect of RASi in solid malignant tumors.

[Download PDF]